Medical Countermeasures Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype PotentialGlobal Biodefense StaffMay 9, 2025
Medical Countermeasures Repositioning Smallpox Vaccines for a New Threat: MpoxGlobal Biodefense StaffMay 8, 2025
Medical Countermeasures New Monoclonal Antibodies Offer Hope for Universal Influenza TreatmentGlobal Biodefense StaffMay 1, 2025
DTRA to Advance Nanostructured Therapeutics for Chem-Bio Defense Contracts + Grants October 22, 2012 …
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine Contracts + Grants October 15, 2012 …
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution Industry News October 13, 2012 …
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
